Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation
Article Date
March 6, 2026
This article is featured on another website.
Go to article
June 15, 2026
European Biopharmaceutical Review – GPCR-modulating Therapies for Solid Tumors: Unlocking a New Frontier in Immuno-oncology
June 15, 2026
European Biopharmaceutical Review – GPCR-modulating Therapies for Solid Tumors: Unlocking a New Frontier in Immuno-oncology
June 5, 2026
Brain Tumors – Still an Area of Significant Unmet Need
The Challenge of Brain Tumors Brain tumors remain a serious challenge due to their complex…
June 5, 2026
Brain Tumors – Still an Area of Significant Unmet Need
The Challenge of Brain Tumors Brain tumors remain a serious challenge due to their complex…